PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Alder pollen is a common cause of seasonal allergies, often appearing early in the pollen season [PMID:36583316, PMID:17655183]. Sensitization to alder pollen often cross-reacts with birch and hazel pollen [PMID:32767165, PMID:7235322, PMID:8946858].
Subcutaneous immunotherapy using a mixture of hazel, alder, and birch pollen was evaluated for safety; most adverse events reported were local reactions [PMID:19339808].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 24330218 (2014) — Allergen hybrids - next generation vaccines for Fagales pollen immunotherapy. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
- 2.PMID: 36583316 (2022) — Influence of meteorological factors on the dynamics of hazel, alder, birch and poplar pollen in the 2021 season in Kielce, Poland. · Annals of agricultural and environmental medicine : AAEM
- 3.PMID: 32767165 (2021) — Does the principle of homologous groups allow a reduction of allergens in the skin prick test panel? · European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
- 4.PMID: 7678615 (1993) — Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. · Journal of immunology (Baltimore, Md. : 1950)